Skip to main content

Table 1 Population

From: Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders

 

Number of patients

Infused patients

11

 Crigler-Najjar

6

  Type 1

5

  Type 2

1

 Urea cycle defect

5

  OTC deficiency

4

  Arginase deficiency

1

Sex

 Female

7

 Male

4

Age at infusion

0.9–16.25 year(s)

Patients per cell dosage

 12.5 × 106/kg

4

 50 × 106/kg

2

 200 × 106/kg

5

Total number of infusions

1–10

Total number of days of infusions

1–4

Completed infusion cycles

7